Natural products as leads to antitumor drugs

Phytochemistry Reviews

Volumn 13, Issue 1, 2014, Pages 123-137

  Newman, David J ^a   Giddings, Lesley Ann ^a  

^a Laboratory of Cancer Prevention   (United States)

Author keywords

Antitumor agents; Marine invertebrates; Microbial commensals; Natural products; Plants

Indexed keywords

ANTINEOPLASTIC AGENT; BOSUTINIB; CABOZANTINIB; CARFILZOMIB; CHONDRAMIDE D; DEHYDRODIDEMNIN B; DIDEMNIN B; DISCODERMIDE; DOLASTATIN; DOLASTATIN DERIVATIVE; ENZALUTAMIDE; EPOTHILONE B; EPOXOMICIN; HISTONE DEACETYLASE INHIBITOR; HOMOHARRINGTONINE; IKARUGAMYCIN; JASPAMIDE; LATRUNCULIN A; MAYTANSINE; NATURAL PRODUCT; PIXURI; PLANT MEDICINAL PRODUCT; PROTEASOME INHIBITOR; RADOTINIB; REGORAFENIB; RENIERAMYCIN A; SAFRACIN B; SAFRAMYCIN A; SAFRAMYCIN B; SAFRAMYCIN C; SUPECT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BIOSYNTHESIS; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HODGKIN DISEASE; HUMAN; INVERTEBRATE; MARINE SPECIES; METABOLITE; MICROORGANISM; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANISMAL INTERACTION; PRIORITY JOURNAL; REVIEW;

INVERTEBRATA;

EID: 84896724238     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-013-9292-6     Document Type: Review

References (51)

1. Aly AH, Edrada-Ebel R, Wray V et al (2008) Bioactive metabolites from the endophytic fungus Ampelomyces sp. isolated from the medicinal plant Urospermum picroides. Phytochem 69:1716-1725
2. Anonymous (1976) Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment. Chin Med J 2:263-272
3. Benelkebir H, Marie S, Hayden AL et al (2011) Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability. Bioorg Med Chem 19:3650-3658
4. Biggins JB, Gleber CD, Brady SF (2011) Acyldepsipeptide HDAC inhibitor production induced in Burkholderia thailandensis. Org Lett 13:1536-1539
5. Crawford JM, Clardy J (2011) Bacterial symbionts and natural products. Chem Comm 47:7559-7566
6. (R). In: Cragg GM, Kingston DGI, Newman DJ (eds) Anticancer agents from natural products. Taylor and Francis, Boca Raton, pp 291-316
7. Dittmer DP, Bhatt AP, Damania B (2012) Rapalogs in viral cancers. Exp Opin Investig Drugs 21:136-138
8. Doi T, Iijima Y, Shin-Ya K et al (2006) A total synthesis of spiruchostatin A. Tet Lett 47:1177-1180 (Pubitemid 43082055)
9. Eustáquio AS, Nam S-J, Penn K et al (2011) The discovery of salinosporamide K from the marine bacterium "Salinispora pacifica" by genome mining gives insight into pathway evolution. ChemBioChem 12:61-64
10. Flahive E, Srirangam J (2012) The Dolastatins: novel antitumor agents from Dolabella auricularia. In: Cragg GM, Kingston DGI, Newman DJ (eds) Anticancer agents from natural products. Taylor and Francis, Boca Raton, pp 263-289
11. Flores-Bustamante ZR, Rivera-Orduna FN, Martinez-Cardenas A et al (2010) Microbial paclitaxel: advances and perspectives. J Antibiot 63:460-467
12. Freel KC, Nam S-J, Fenical W et al (2011) Evolution of secondary metabolite genes in three closely related marine actinomycete species. Appl Environ Micro 77:7261-7270
13. Frincke JM, Faulkner DJ (1982) Antimicrobial metabolites of the sponge Reniera sp. J Am Chem Soc 104:265-269
14. Gunatilaka AAL (2006) Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence. J Nat Prod 69:509-526
15. Hanada M, Sugawara K, Kaneta K et al (1992) Epoxomicin, a new antitumor agent of microbial origin. J Antibiot 45:1746-1752 (Pubitemid 23015454)
16. Hentschel U, Piel J, Degnan SM et al (2012) Genomic insights into the marine sponge microbiome. Nat Rev Microbiol 10:641-654
17. Higashide E, Asai M, Ootsu K et al (1977) Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia 721. Nature 270:721-722 (Pubitemid 8239243)
18. Hong J, Luesch H (2012) Largazole: from discovery to broad-spectrum therapy. Nat Prod Rep 29:449-456
19. Kim KB, Myung J, Sin N et al (1999) Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. Bioorg Med Chem Lett 9:3335-3340
20. Kuemler I, Mortensen CE, Nielsen DL (2011) Trastuzumab emtansine. Drugs Fut 36:825-832
21. Kupchan SM, Komoda Y, Court WA et al (1972) Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J Am Chem Soc 94:1354-1356
22. Lambert JM (2010) Antibody-maytansinoid conjugates: a new strategy for the treatment of cancer.Drugs Future 35:471-480
23. Lee J, Currano JN, Carroll PJ et al (2012) Didemnins, tamandarins and related natural products. Nat Prod Rep 29:404-424
24. Luesch H, Harrigan GG, Goetz G et al (2002) The cyanobacterial origin of potent anticancer agents originally isolated from sea hares. Curr Med Chem 9:1791-1806
25. Masuoka Y, Nagai A, Shin-ya K et al (2001) Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp. Tet Letts 42:41-44 (Pubitemid 32011701)
26. Moss C, Green DH, Perez B et al (2003) Intracellular bacteria associated with the ascidian Ecteinascidia turbinata: phylogenetic and in situ hybridisation analysis. Mar Biol 143:99-110 (Pubitemid 36967327)
27. Nakao Y, Shiroiwa T, Murayama S et al (2004) Identification of Renieramycin A as an antileishmanial substance in a marine sponge Neopetrosia sp. Mar Drugs 2:55-62
28. Newman DJ (2008) Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem 51:2589-2599
29. Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311-335
30. Nützmann H-W, Schroeckh V, Brakhage AA (2012) Regulatory cross talk and microbial induction of fungal secondary metabolite gene clusters. Methods Enzymol 517:325-341
31. Pahirulzaman KAK, Williams K, Lazarus CM (2012) A toolkit for heterologous expression of metabolic pathways in Aspergillus oryzae. Meth Enzymol 517:241-260
32. Parez-Matos AE, Rosado W, Govind NS (2007) Bacterial diversity associated with the Caribbean tunicate Ecteinascidia turbinata. Antonie Van Leeuwenhoek 92:155-164 (Pubitemid 47062596)
33. Piel J (2006) Bacterial symbionts: prospects for the sustainable production of invertebrate-derived pharmaceuticals. Curr Med Chem 13:39-50
34. Piel J (2010) Biosynthesis of polyketides by trans-AT polyketide synthases. Nat Prod Rep 27:996-1047
35. Pópulo H, Lopes JM, Soares P (2012) The mTOR signalling pathway in human cancer. Int J Mol Sci 13:1886-1918
36. Prado S, Li Y, Nay B (2012) Diversity and ecological significance of fungal endophyte natural products. In: Rahman AU (ed) Studies in natural products chemistry. Elsevier, Amsterdam, pp 246-296
37. Rath CM, Janto B, Earl J et al (2011) Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. ACS Chem Biol 6:1244-1256
38. Sanchez JF, Somoza AD, Keller NP et al (2012) Advances in Aspergillus secondary metabolite research in the postgenomic era. Nat Prod Rep 29:351-371
39. Scherlach K, Busch B, Lackner G et al (2012) Symbiotic cooperation in the biosynthesis of a phytotoxin. Angew Chem Int Ed 51:9615-9618
40. Schmidt EW, Donia MS, McIntosh JA et al (2012) Origin and variation of tunicate secondary metabolites. J Nat Prod 75:295-304
41. Seyedsayamdost MR, Traxler MF, Clardy J et al (2012) Old meets new: using interspecies interactions to detect secondary metabolite production in actinomycetes. Methods Enzymol 517:89-109
42. Sin N, Kim KB, Elofsson M et al (1999) Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorg Med Chem Lett 9:2283-2288 (Pubitemid 29371952)
43. Staniek A, Woerdenbag HJ, Kayser O (2009) Taxomyces andreanae: a presumed paclitaxel producer demystified? Planta Med 75:1561-1566
44. Taori K, Paul VJ, Luesch H (2008) Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp. J Am Chem Soc 130:1806-1807 (Pubitemid 351238618)
45. Tsukimoto M, Nagaoka M, Shishido Y et al (2011) Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B. J Nat Prod 74:2329-2331
46. Ueda H, Nakajima H, Hori Y et al (1994) FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot 47:301-310 (Pubitemid 24106520)
47. Wang C, Flemming CJ, Cheng Y-Q (2012) Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from Burkholderia thailandensis E264. MedChemComm 3:976-981
48. Wawrzyn GT, Bloch SE, Schmidt-Dannert C (2012) Discovery and characterization of terpenoid biosynthetic pathways of fungi. Meth Enzymol 515:83-105
49. Winter JM, Behnken S, Hertweck C (2011) Genomics-inspired discovery of natural products. Curr Opin Chem Biol 15:22-31
50. Xu Y, Kersten RD, Nam S-J et al (2012) Bacterial biosynthesis and maturation of the didemnin anti-cancer agents. J Am Chem Soc 134:8625-8632
51. Yu T-W, Floss HG, Cragg GM et al (2012) Ansamitocins (Maytansenoids). In: Cragg GM, Kingston DGI, Newman DJ (eds) Anticancer agents from natural products. Taylor and Francis, Boca Raton, pp 407-427